Discontinued — last reported Q4 '25

Business Segments · Restructuring Charges

Manufacturing, Research, Corporate — Restructuring Charges

Zoetis Manufacturing, Research, Corporate — Restructuring Charges remained flat by 0.0% to $10.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 200.0%, from $3.50M to $10.50M. Over 4 years (FY 2021 to FY 2025), Manufacturing, Research, Corporate — Restructuring Charges shows an upward trend with a 18.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

An increase suggests significant organizational change or cost-cutting initiatives, while a decrease indicates a period of operational stability.

Detailed definition

This metric represents the costs associated with the reorganization, consolidation, or streamlining of manufacturing, re...

Peer comparison

Peers in the pharmaceutical and animal health sectors report similar charges as 'Restructuring' or 'Special Items' when undergoing integration or cost-optimization programs.

Metric ID: zts_segment_manufacturing_research_corporate_restructuring_charges

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$21.00M$2.00M$22.00M$14.00M$42.00M
YoY Change-90.5%>999%-36.4%+200.0%
Range$2.00M$42.00M
CAGR+18.9%
Avg YoY Growth+268.3%
Median YoY Growth+81.8%

Frequently Asked Questions

What is Zoetis's manufacturing, research, corporate — restructuring charges?
Zoetis (ZTS) reported manufacturing, research, corporate — restructuring charges of $10.50M in Q4 2025.
How has Zoetis's manufacturing, research, corporate — restructuring charges changed year-over-year?
Zoetis's manufacturing, research, corporate — restructuring charges increased by 200.0% year-over-year, from $3.50M to $10.50M.
What is the long-term trend for Zoetis's manufacturing, research, corporate — restructuring charges?
Over 4 years (2021 to 2025), Zoetis's manufacturing, research, corporate — restructuring charges has grown at a 18.9% compound annual growth rate (CAGR), from $21.00M to $42.00M.
What does manufacturing, research, corporate — restructuring charges mean?
The costs incurred to reorganize or downsize the company's manufacturing, research, and administrative functions.